Bariatric surgery in obese patients with ventricular assist devices

Autor: Yuhamy Curbelo-Pena, Juan Francisco Loro-Ferrer, Hector O. Ventura, Carl J. Lavie, Stacy A. Mandras, Bader Aldeen Alhafez, Adrian daSilva-deAbreu
Rok vydání: 2020
Předmět:
0301 basic medicine
medicine.medical_specialty
Sleeve gastrectomy
Gastric bypass
Roux-en-Y gastric bypass
medicine.medical_treatment
lcsh:Medicine
Heart failure
Heart transplantation
Data Note
General Biochemistry
Genetics and Molecular Biology
Body Mass Index
Ventricular assist devices
03 medical and health sciences
0302 clinical medicine
Gastrectomy
Weight Loss
medicine
Humans
Statistical analysis
Obesity
030212 general & internal medicine
lcsh:Science (General)
lcsh:QH301-705.5
Retrospective Studies
Bariatric surgery
business.industry
Individual participant data
lcsh:R
General Medicine
medicine.disease
Obesity
Morbid
Surgery
Treatment Outcome
030104 developmental biology
lcsh:Biology (General)
Laparoscopy
Heart-assist devices
medicine.symptom
business
Weight gain
Body mass index
lcsh:Q1-390
Zdroj: BMC Research Notes
BMC Research Notes, Vol 13, Iss 1, Pp 1-3 (2020)
ISSN: 1756-0500
DOI: 10.1186/s13104-020-05221-z
Popis: Objectives Patients with end-stage heart failure (ESHF) treated with ventricular assist devices (VADs) tend to gain weight, which may prevent them from receiving heart transplantation (HT) if their body mass index (BMI) reaches ≥ 35 kg/m2. The objective was to synthesize all cases available in the literature and describe the most important outcomes of bariatric surgery (BS) in VAD patients, including BMI trends, reaching a BMI 2, listing for HT, achieving HT, myocardial recovery, and mortality. These data were obtained for an individual participant data (IPD) meta-analysis and include available IPD for every case in the scientific literature describing VAD patients undergoing BS during VAD support with documented postoperative BMI (and time of measurement) during follow-up. Data description These data include baseline, periprocedural, and long-term outcomes for the 29 patients meeting selection criteria. The composite outcome includes reaching a BMI 2, listing for HT, receiving HT, and myocardial recovery, indicating significant BMI loss associated with major ESHF outcomes. As multiple centers are becoming more experienced in this field, the present data can be merged with their databases to form larger samples that will allow to perform further statistical analysis to identify outcome predictors and improve clinical protocols and outcomes.
Databáze: OpenAIRE
Externí odkaz: